ArticleBlood advances2026
Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.
Hisayuki Yokoyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleBlood advances2026
Hisayuki Yokoyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.